8-60678764-C-CGCGGCG
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_017780.4(CHD7):c.-472_-467dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.092 ( 801 hom., cov: 0)
Exomes 𝑓: 0.069 ( 3 hom. )
Consequence
CHD7
NM_017780.4 5_prime_UTR
NM_017780.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.400
Genes affected
CHD7 (HGNC:20626): (chromodomain helicase DNA binding protein 7) This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHD7 | NM_017780.4 | c.-472_-467dup | 5_prime_UTR_variant | 1/38 | ENST00000423902.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.-472_-467dup | 5_prime_UTR_variant | 1/38 | 5 | NM_017780.4 | P1 | ||
CHD7 | ENST00000695848.1 | n.42_47dup | non_coding_transcript_exon_variant | 1/7 | |||||
CHD7 | ENST00000695849.1 | n.42_47dup | non_coding_transcript_exon_variant | 1/7 | |||||
CHD7 | ENST00000695853.1 | c.-472_-467dup | 5_prime_UTR_variant, NMD_transcript_variant | 1/37 |
Frequencies
GnomAD3 genomes AF: 0.0921 AC: 12663AN: 137510Hom.: 801 Cov.: 0
GnomAD3 genomes
AF:
AC:
12663
AN:
137510
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0686 AC: 42AN: 612Hom.: 3 Cov.: 0 AF XY: 0.0514 AC XY: 18AN XY: 350
GnomAD4 exome
AF:
AC:
42
AN:
612
Hom.:
Cov.:
0
AF XY:
AC XY:
18
AN XY:
350
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0921 AC: 12665AN: 137504Hom.: 801 Cov.: 0 AF XY: 0.0913 AC XY: 6085AN XY: 66660
GnomAD4 genome
AF:
AC:
12665
AN:
137504
Hom.:
Cov.:
0
AF XY:
AC XY:
6085
AN XY:
66660
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
CHARGE syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Hypogonadism with anosmia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at